Education
About Us
Working with TipRanks
Follow Us
Viridian Therapeutics (VRDN)
NASDAQ:VRDN
Viridian Therapeutics (VRDN) Ownership Overview
4.26% Insiders
26.28% Mutual Funds
0.28% Other Institutional Investors
11.59% ETFs
57.59% Public Companies and Individual Investors
The ownership structure of Viridian Therapeutics (VRDN) stock is a mix of institutional, retail, and individual investors. Approximately 38.14% of the company’s stock is owned by Institutional Investors, 4.26% is owned by Insiders, and 57.59% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 30, 2024 | xxxxxxxxxxxxx | $499262 | |
Sep 17, 2024 | xxxxxxxxxxxxx | $30000000 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,949,637 | Institution | 4.84% | 51,108,303 | |
| 3,445,813 | Institution | 4.22% | 44,588,820 | |
| 3,445,813 | Insider | 4.22% | 44,588,820 | |
| 3,302,098 | Institution | 4.05% | 42,729,148 | |
| 3,270,666 | Institution | 4.01% | 42,322,418 | |
| 3,019,514 | Institution | 3.70% | 39,072,511 | |
| 2,927,936 | Institution | 3.59% | 37,887,492 | |
| 2,499,248 | Institution | 3.06% | 32,340,269 | |
| 2,061,274 | Institution | 2.53% | 26,672,886 | |
| 1,391,841 | Institution | 1.71% | 18,010,423 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,302,098 | Institution | 4.05% | 42,729,148 | |
| 3,270,666 | Institution | 4.01% | 42,322,418 | |
| 2,927,936 | Institution | 3.59% | 37,887,492 | |
| 2,499,248 | Institution | 3.06% | 32,340,269 | |
| 1,162,012 | Institution | 1.42% | 15,036,435 | |
| 971,749 | Institution | 1.19% | 12,574,432 | |
| 818,152 | Institution | 1.00% | 10,586,887 | |
| 805,239 | Institution | 0.99% | 10,419,793 | |
| 783,911 | Institution | 0.96% | 10,143,808 | |
| 620,815 | Institution | 0.76% | 8,033,346 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,263,268 | Institution | 2.77% | 30,667,281 | |
| 1,902,813 | Institution | 2.33% | 24,622,400 | |
| 1,263,541 | Institution | 1.55% | 15,945,887 | |
| 1,069,203 | Institution | 1.31% | 14,487,701 | |
| 484,169 | Institution | 0.59% | 6,265,147 | |
| 373,477 | Institution | 0.46% | 5,060,613 | |
| 322,429 | Institution | 0.40% | 4,069,054 | |
| 182,350 | Institution | 0.22% | 2,359,609 | |
| 173,661 | Institution | 0.21% | 2,353,107 | |
| 152,384 | Institution | 0.19% | 1,971,849 |
FAQ
Who Owns Viridian Therapeutics (VRDN)?
According to the latest TipRanks data, approximately 0.28% of the company's stock is held by institutional investors, 4.26% is held by insiders, and 57.59% is held by retail investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.28% of Viridian Therapeutics (VRDN) stock is held by institutional investors.
What percentage of Viridian Therapeutics (VRDN) stock is held by retail investors?
According to the latest TipRanks data, approximately 57.59% of Viridian Therapeutics (VRDN) stock is held by retail investors.
Who owns the most shares of Viridian Therapeutics (VRDN)?
Vanguard owns the most shares of Viridian Therapeutics (VRDN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.